Nanexa AB (publ) (NANEXA.ST)
- Previous Close
2.0500 - Open
2.0950 - Bid 2.3150 x --
- Ask 2.3300 x --
- Day's Range
2.0550 - 2.3900 - 52 Week Range
0.7010 - 3.1500 - Volume
2,425,371 - Avg. Volume
476,441 - Market Cap (intraday)
365.596M - Beta (5Y Monthly) 1.86
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1800 - Earnings Date May 6, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nanexa AB (publ) operates as a nanotechnology drug delivery company. The company operates PharmaShell, a drug delivery system that is an atomic layer deposition. It also develops NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
www.nanexa.com13
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: NANEXA.ST
View MorePerformance Overview: NANEXA.ST
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NANEXA.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NANEXA.ST
View MoreValuation Measures
Market Cap
365.60M
Enterprise Value
359.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.98
Price/Book (mrq)
5.15
Enterprise Value/Revenue
14.74
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-53.34%
Return on Assets (ttm)
-14.61%
Return on Equity (ttm)
-29.87%
Revenue (ttm)
46.69M
Net Income Avi to Common (ttm)
-24.91M
Diluted EPS (ttm)
-0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
10.29M
Total Debt/Equity (mrq)
5.22%
Levered Free Cash Flow (ttm)
-42.47M